Editorial Comment to Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection

Satoshi Yazawa; Naoki Hasegawa; Mototsugu Oya

doi:10.1111/iju.14199

Editorial Comment to Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection

Satoshi Yazawa, Naoki Hasegawa, Mototsugu Oya

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	248-249
Number of pages	2
Journal	International Journal of Urology
Volume	27
Issue number	3
DOIs	https://doi.org/10.1111/iju.14199
Publication status	Published - 2020 Mar 1

ASJC Scopus subject areas

Urology

Access to Document

10.1111/iju.14199

Cite this

Yazawa, S., Hasegawa, N., & Oya, M. (2020). Editorial Comment to Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection. International Journal of Urology, 27(3), 248-249. https://doi.org/10.1111/iju.14199

Editorial Comment to Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection. / Yazawa, Satoshi; Hasegawa, Naoki ; Oya, Mototsugu.
In: International Journal of Urology, Vol. 27, No. 3, 01.03.2020, p. 248-249.

Research output: Contribution to journal › Comment/debate › peer-review

Yazawa, S, Hasegawa, N & Oya, M 2020, 'Editorial Comment to Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection', International Journal of Urology, vol. 27, no. 3, pp. 248-249. https://doi.org/10.1111/iju.14199

Yazawa, Satoshi ; Hasegawa, Naoki ; Oya, Mototsugu. / Editorial Comment to Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate : A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection. In: International Journal of Urology. 2020 ; Vol. 27, No. 3. pp. 248-249.

@article{b0a23c183156468481d56b5c9187836c,

title = "Editorial Comment to Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection",

author = "Satoshi Yazawa and Naoki Hasegawa and Mototsugu Oya",

year = "2020",

month = mar,

day = "1",

doi = "10.1111/iju.14199",

language = "English",

volume = "27",

pages = "248--249",

journal = "International Journal of Urology",

issn = "0919-8172",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Editorial Comment to Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate

T2 - A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection

AU - Yazawa, Satoshi

AU - Hasegawa, Naoki

AU - Oya, Mototsugu

PY - 2020/3/1

Y1 - 2020/3/1

UR - http://www.scopus.com/inward/record.url?scp=85079718565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079718565&partnerID=8YFLogxK

U2 - 10.1111/iju.14199

DO - 10.1111/iju.14199

M3 - Comment/debate

C2 - 32056318

AN - SCOPUS:85079718565

SN - 0919-8172

VL - 27

SP - 248

EP - 249

JO - International Journal of Urology

JF - International Journal of Urology

IS - 3

ER -

Editorial Comment to Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract Infection

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this